No Data
Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E No Reason For Excitement
Hualan Biological Engineering, Inc. (002007.SZ): The Chairman, the actual controller, some directors, and senior executives completed a Shareholding of a total of 1.4957 million shares.
Gelonghui, January 8th丨Hualan Biological Engineering, Inc. (002007.SZ) announced that as of January 8, 2025, the relevant shareholding plan period has expired and the plan has been fully implemented. The chairman, actual controller, some directors, and senior management personnel have collectively increased their shareholding by 1.4957 million shares, all of which are not less than their respective promised minimum shareholding quantities.
Hualan Biological Engineering Inc.'s (SZSE:002007) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Are Investors Undervaluing Hualan Biological Engineering Inc. (SZSE:002007) By 42%?
Hualan Biological Engineering, Inc. (002007.SZ): The company has obtained a single-sourced plasma collection license.
On December 4, Gelonghui reported that hualan biological engineering, inc. (002007.SZ) announced that on December 4, 2024, the company's wholly-owned subsidiary, hualan biological engineering chongqing co., ltd., received the "Plasma Collection License" issued by the Chongqing Municipal Health Committee for the hualan plasma collection station in Wushan County, Chongqing (hereinafter referred to as "Wushan Plasma Station"). The Wushan Plasma Station can officially begin plasma collection from the date it obtains the "Plasma Collection License." The operation of plasma collection at the Wushan Plasma Station will help enhance the company's supply capacity of raw plasma, which will have a positive impact on the company's long-term development.
Hualan Biological Engineering's Unit Gets Certificate for Cancer Drug's Registration
Some Confidence Is Lacking In Hualan Biological Engineering Inc.'s (SZSE:002007) P/E
